174 related articles for article (PubMed ID: 20575220)
1. Gone (from the Physicians' desk reference) but not forgotten: propylthiouracil-associated hepatic failure: a call for liver test monitoring.
Primeggia J; Lewis JH
J Natl Med Assoc; 2010 Jun; 102(6):531-4. PubMed ID: 20575220
[TBL] [Abstract][Full Text] [Related]
2. [Propylthiouracil-induced overt hepatic injury in patients with hyperthyroidism].
Lian XL; Bai Y; Dai WX; Guo ZS; Li W; Lu L
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Apr; 26(2):172-7. PubMed ID: 15171556
[TBL] [Abstract][Full Text] [Related]
3. [The clinical characteristics of symptomatic propylthiouracil-induced hepatic injury in patients with hyperthyroidism].
Lian XL; Bai Y; Dai WX; Jin ZM; Zeng ZP; Guo ZS
Zhonghua Nei Ke Za Zhi; 2004 Jun; 43(6):442-6. PubMed ID: 15312442
[TBL] [Abstract][Full Text] [Related]
4. The propylthiouracil dilemma.
Glinoer D; Cooper DS
Curr Opin Endocrinol Diabetes Obes; 2012 Oct; 19(5):402-7. PubMed ID: 22820213
[TBL] [Abstract][Full Text] [Related]
5. The incidence and clinical characteristics of symptomatic propylthiouracil-induced hepatic injury in patients with hyperthyroidism: a single-center retrospective study.
Kim HJ; Kim BH; Han YS; Yang I; Kim KJ; Dong SH; Kim HJ; Chang YW; Lee JI; Chang R
Am J Gastroenterol; 2001 Jan; 96(1):165-9. PubMed ID: 11197248
[TBL] [Abstract][Full Text] [Related]
6. A case of autoimmune hepatitis with Graves' disease treated by propylthiouracil.
Sato I; Tsunekawa T; Shinohara Y; Nishio Y; Shimizu Y; Suzuki Y; Yoshioka S
Nagoya J Med Sci; 2011 Aug; 73(3-4):205-9. PubMed ID: 21928702
[TBL] [Abstract][Full Text] [Related]
7. [Asymptomatic hepatitis induced by propylthiouracil].
De Castro JJ; Nobre EL; Garcia e Costa J; Galvão-Teles A
Acta Med Port; 2001; 14(5-6):523-7. PubMed ID: 11878166
[TBL] [Abstract][Full Text] [Related]
8. Propylthiouracil hepatitis: report of a case and extensive review of the literature.
Memi E; Karras S; Tzotzas T; Krassas GE
J Pediatr Endocrinol Metab; 2012; 25(3-4):331-43. PubMed ID: 22768665
[TBL] [Abstract][Full Text] [Related]
9. Propylthiouracil-induced severe hepatitis: a case report and review of the literature.
Ichiki Y; Akahoshi M; Yamashita N; Morita C; Maruyama T; Horiuchi T; Hayashida K; Ishibashi H; Niho Y
J Gastroenterol; 1998 Oct; 33(5):747-50. PubMed ID: 9773944
[TBL] [Abstract][Full Text] [Related]
10. Changes in liver biochemical tests at diagnosis and after propylthiouracil therapy for hyperthyroidism.
Gürlek A; Cobankara V; Bayraktar M
Mater Med Pol; 1996; 28(3):103-6. PubMed ID: 9167420
[TBL] [Abstract][Full Text] [Related]
11. A fatal case of propylthiouracil-induced ANCA-associated vasculitis resulting in rapidly progressive glomerulonephritis, acute hepatic failure, and cerebral angiitis.
Khan TA; Yin Luk FC; Uqdah HT; Arif A; Hussain H; Jayatilleke A; Aggarwal S
Clin Nephrol; 2015 May; 83(5):309-14. PubMed ID: 25208313
[TBL] [Abstract][Full Text] [Related]
12. Severe hepatotoxicity on beginning propylthiouracil therapy.
Lock DR; Sthoeger ZM
J Clin Gastroenterol; 1997 Jun; 24(4):267-9. PubMed ID: 9252857
[TBL] [Abstract][Full Text] [Related]
13. Drug-Induced Liver Injury: A Unique Presentation of Single-Dose Administration of Propylthiouracil.
Weissman S; Rajaratnam NG; Qureshi N; Inayat F; Elias S
J Investig Med High Impact Case Rep; 2020; 8():2324709620951323. PubMed ID: 32830568
[TBL] [Abstract][Full Text] [Related]
14. Antineutrophilic cytoplasmic antibody-positive systemic vasculitis associated with propylthiouracil therapy: report of 2 children with Graves' disease.
Poomthavorn P; Mahachoklertwattana P; Tapaneya-Olarn W; Chuansumrit A; Chunharas A
J Med Assoc Thai; 2002 Nov; 85 Suppl 4():S1295-301. PubMed ID: 12549809
[TBL] [Abstract][Full Text] [Related]
15. Propylthiouracil-induced hepatic damage.
Ozenírler S; Tuncer C; Boztepe U; Akyol G; Alkim H; Cakir N; Kandílć U
Ann Pharmacother; 1996 Sep; 30(9):960-3. PubMed ID: 8876856
[TBL] [Abstract][Full Text] [Related]
16. Propylthiouracil-associated liver failure presenting as probable autoimmune hepatitis in a child with Graves' disease.
Sipe WE; Su M; Posselt A; Kim GE; Quiros JA; Rosenthal P
Pediatr Transplant; 2006 Jun; 10(4):525-8. PubMed ID: 16712616
[TBL] [Abstract][Full Text] [Related]
17. Liver tests in hyperthyroidism: effect of antithyroid therapy.
Gürlek A; Cobankara V; Bayraktar M
J Clin Gastroenterol; 1997 Apr; 24(3):180-3. PubMed ID: 9179740
[TBL] [Abstract][Full Text] [Related]
18. Propylthiouracil, and methimazole, and carbimazole-related hepatotoxicity.
Akmal A; Kung J
Expert Opin Drug Saf; 2014 Oct; 13(10):1397-406. PubMed ID: 25156887
[TBL] [Abstract][Full Text] [Related]
19. Successful treatment with carbimazole of a hyperthyroid pregnancy with hepatic impairment after propylthiouracil administration: a case report.
Kontoleon P; Ilias I; Koutras DA; Kontogiannis D; Papapetrou PD
Clin Exp Obstet Gynecol; 2002; 29(4):304-5. PubMed ID: 12635752
[TBL] [Abstract][Full Text] [Related]
20. The Role of Propylthiouracil in the Management of Graves' Disease in Adults: report of a meeting jointly sponsored by the American Thyroid Association and the Food and Drug Administration.
Bahn RS; Burch HS; Cooper DS; Garber JR; Greenlee CM; Klein IL; Laurberg P; McDougall IR; Rivkees SA; Ross D; Sosa JA; Stan MN
Thyroid; 2009 Jul; 19(7):673-4. PubMed ID: 19583480
[No Abstract] [Full Text] [Related]
[Next] [New Search]
